As of 2025-09-18, the Relative Valuation of Celldex Therapeutics Inc (CLDX) is (59.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.46 USD, the upside of Celldex Therapeutics Inc based on Relative Valuation is -345.2%.
The range of the Relative Valuation is (51.10) - (61.98) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 20.6x | 18.1x |
| Forward P/E multiples | 17.0x - 26.6x | 21.8x |
| Fair Price | (51.10) - (61.98) | (59.96) |
| Upside | -308.9% - -353.4% | -345.2% |
| Date | P/E |
| 2025-09-11 | -8.38 |
| 2025-09-10 | -8.30 |
| 2025-09-09 | -8.08 |
| 2025-09-08 | -7.79 |
| 2025-09-05 | -7.61 |
| 2025-09-04 | -7.58 |
| 2025-09-03 | -7.86 |
| 2025-09-02 | -7.34 |
| 2025-08-29 | -7.35 |
| 2025-08-28 | -7.45 |
| 2025-08-27 | -7.52 |
| 2025-08-26 | -7.24 |
| 2025-08-25 | -7.30 |
| 2025-08-22 | -7.47 |
| 2025-08-21 | -7.33 |
| 2025-08-20 | -6.95 |
| 2025-08-19 | -7.99 |
| 2025-08-18 | -8.14 |
| 2025-08-15 | -8.48 |
| 2025-08-14 | -8.30 |
| 2025-08-13 | -8.31 |
| 2025-08-12 | -7.92 |
| 2025-08-11 | -6.66 |
| 2025-08-08 | -6.87 |
| 2025-08-07 | -7.06 |
| 2025-08-06 | -7.13 |
| 2025-08-05 | -7.36 |
| 2025-08-04 | -7.25 |
| 2025-08-01 | -7.38 |
| 2025-07-31 | -7.31 |
| 2025-07-30 | -7.59 |
| 2025-07-29 | -7.30 |
| 2025-07-28 | -7.32 |
| 2025-07-25 | -7.77 |
| 2025-07-24 | -7.73 |
| 2025-07-23 | -7.94 |
| 2025-07-22 | -7.44 |
| 2025-07-21 | -7.34 |
| 2025-07-18 | -7.46 |
| 2025-07-17 | -7.64 |
| 2025-07-16 | -7.65 |
| 2025-07-15 | -7.60 |
| 2025-07-14 | -7.77 |
| 2025-07-11 | -7.62 |
| 2025-07-10 | -7.55 |
| 2025-07-09 | -7.47 |
| 2025-07-08 | -7.10 |
| 2025-07-07 | -6.98 |
| 2025-07-03 | -7.32 |
| 2025-07-02 | -7.36 |